ATE339434T1 - Basenanaloge - Google Patents

Basenanaloge

Info

Publication number
ATE339434T1
ATE339434T1 AT01947617T AT01947617T ATE339434T1 AT E339434 T1 ATE339434 T1 AT E339434T1 AT 01947617 T AT01947617 T AT 01947617T AT 01947617 T AT01947617 T AT 01947617T AT E339434 T1 ATE339434 T1 AT E339434T1
Authority
AT
Austria
Prior art keywords
alkynyl
sugar
alkenyl
novel compounds
alkyl
Prior art date
Application number
AT01947617T
Other languages
English (en)
Inventor
Shiv Kumar
Mark Mcdougall
Satyam Nampalli
Constantin Neagu
David Loakes
Dan Brown
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE339434T1 publication Critical patent/ATE339434T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/117Modifications characterised by incorporating modified base

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Laminated Bodies (AREA)
  • Photoreceptors In Electrophotography (AREA)
AT01947617T 2000-07-03 2001-06-29 Basenanaloge ATE339434T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016258.6A GB0016258D0 (en) 2000-07-03 2000-07-03 Base analogues

Publications (1)

Publication Number Publication Date
ATE339434T1 true ATE339434T1 (de) 2006-10-15

Family

ID=9894887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01947617T ATE339434T1 (de) 2000-07-03 2001-06-29 Basenanaloge

Country Status (11)

Country Link
US (1) US6664058B2 (de)
EP (1) EP1296997B1 (de)
JP (1) JP2004502701A (de)
AT (1) ATE339434T1 (de)
AU (1) AU2001269264A1 (de)
CA (1) CA2412292A1 (de)
DE (1) DE60123056T2 (de)
DK (1) DK1296997T3 (de)
ES (1) ES2271036T3 (de)
GB (1) GB0016258D0 (de)
WO (1) WO2002002584A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
CA2440754A1 (en) 2001-03-12 2002-09-19 Stephen Quake Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
EP1716254B1 (de) 2004-02-19 2010-04-07 Helicos Biosciences Corporation Verfahren zur analyse von polynukleotidsequenzen
EP1766090B1 (de) 2004-05-25 2011-04-27 Helicos Biosciences Corporation Verfahren zur nukleinsäureimmobilisierung
US7476734B2 (en) 2005-12-06 2009-01-13 Helicos Biosciences Corporation Nucleotide analogs
US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing
US7482120B2 (en) 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US7397546B2 (en) 2006-03-08 2008-07-08 Helicos Biosciences Corporation Systems and methods for reducing detected intensity non-uniformity in a laser beam
CN117481869A (zh) 2018-01-25 2024-02-02 爱德华兹生命科学公司 在部署后用于辅助置换瓣膜重新捕获和重新定位的递送系统
JP7319990B2 (ja) 2018-03-21 2023-08-02 エフ. ホフマン-ラ ロシュ アーゲー メチル化dNTPを効率的かつ効果的に組み込むDNAポリメラーゼ
EP3833762A4 (de) 2018-08-09 2022-09-28 Verseau Therapeutics, Inc. Oligonukleotidzusammensetzungen zum targeting von ccr2 und csf1r und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602025D0 (en) * 1996-02-01 1996-04-03 Amersham Int Plc Nucleoside analogues
GB9716231D0 (en) * 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues

Also Published As

Publication number Publication date
DE60123056D1 (de) 2006-10-26
CA2412292A1 (en) 2002-01-10
JP2004502701A (ja) 2004-01-29
ES2271036T3 (es) 2007-04-16
EP1296997B1 (de) 2006-09-13
US20020137695A1 (en) 2002-09-26
EP1296997A1 (de) 2003-04-02
WO2002002584A1 (en) 2002-01-10
US6664058B2 (en) 2003-12-16
AU2001269264A1 (en) 2002-01-14
DE60123056T2 (de) 2007-01-18
GB0016258D0 (en) 2000-08-23
DK1296997T3 (da) 2007-01-02

Similar Documents

Publication Publication Date Title
ATE339434T1 (de) Basenanaloge
EP1013661A4 (de) Bicyclonukleosid- und oligonukleotid-analoga
ATE232880T1 (de) Neue nucleotidanaloga
MXPA02011896A (es) Produccion combinatoria de analogos de nucleotidos y nucleosidos (xitp).
DK0691980T3 (da) 7-deazapurinmodifiderende oligonukleotider
DK1221955T3 (da) Immunstimulerende nukleinsyre
DE60015388D1 (de) Zusammensetzung daraus hergestellte gegenstände
WO2000061151A3 (en) Oligodeoxynucleotide and its use to induce an immune response
PL328639A1 (en) Synthesis of p5' phosphoamidane oligonucleotides n3'
DK1218545T3 (da) Fremgangsmåder til fremstilling af oligonukleotidopløsninger
WO2003014080A3 (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
EP0266168A3 (de) Zusammensetzungen und Verfahren zur Herstellung von Oligonukleotiden, deren 5' Ende phosphoryliert ist
ATE251131T1 (de) Feinteilige form von (s)-2-ethoxy -3- 4-(2- 4- methansulfonyloxyphenyl ethoxy)phenyl)propansäure
WO2000040590A3 (fr) Compose fonctionnalise, polynucleotide eventuellement marque et procede de detection d'un acide nucleique cible
EP1418949A4 (de) Dna-methylierungshemmer
EP1829861A3 (de) Als Oxytocinantagonisten wirksame Pyrrolidinesterderivate
WO2002044398A3 (en) Universal supports for oligonucleotide synthesis
DE60335805D1 (de) Verfahren zur herstellung von 1,3-dioxolan-nucleosiden
EP1312608A3 (de) Discodermolid-Analoga und ihre pharmazeutische Verwendung
DE60203998D1 (de) Verfahren zur herstellung von (e)-5-(2-bromovinyl)-2'-deoxyuridin
DE59809538D1 (de) Verfahren zur Herstellung von 1,2,3,6-Tetrahydro-2,2,6,6-tetramethylpyridin
DE50107987D1 (de) Verfahren zur herstellung von 2,3,5,6-tetrahalogen-xylylidenverbindungen
EP1300395A4 (de) 4-substituierte piperidinverbindung
DK1537210T3 (da) Decoy-oligonukleotid-inhibering af CD40-ekspression
DE60226471D1 (de) Verfahren zur herstellung von (pyrimidin-2-yl)methylketonen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties